Gossamer Bio: Gossamer Bio GAAP EPS of -$0.15 beats by $0.01, revenue of $9.34M beats by $2.32M

Gossamer Bio is a California-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of cancer and inflammatory diseases.